KAT5 Inhibitor NU9056 Suppresses Anaplastic Thyroid Carcinoma Progression through c-Myc/miR-202 Pathway

BACKGROUND: Anaplastic thyroid carcinoma (ATC) is considered to be one of the most aggressive cancers. Our previous study proved that highly expressed lysine acetyltransferase 5 (KAT5) in ATC is associated with a poorer prognosis. Here, this study examined the effects of a KAT5 inhibitor (NU9056) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Wenjing, Xie, Liwei, Yang, Yingying, Xu, Jiayu, Cai, Shang, Tian, Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279498/
https://www.ncbi.nlm.nih.gov/pubmed/37342240
http://dx.doi.org/10.1155/2022/2014568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279498/
https://www.ncbi.nlm.nih.gov/pubmed/37342240
http://dx.doi.org/10.1155/2022/2014568

Ejemplares similares